Sign in to view content

Intravitreal Avacincaptad Pegol in Geographic Atrophy: Post-Hoc Analysis of Vision Loss From the GATHER Clinical Program

Carl J Danzig, MD

Video
Published 2023

Related

How Do I Decide to Treat Patients with Geographic Atrophy?
Glenn J. Jaffe, MD
Updates from the Field
2024
Preliminary Results from a First-in-human Phase I/II Gene Therapy Study (FOCUS) of Subretinally Delivered GT005, an Investigational AAV2 Vector, in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration
Jared S. Nielsen, MD, MBA
Updates from the Field
2022
Subretinal Implantation of a Bioengineered Embryonic Stem Cell-Derived Retinal Pigment Epithelium Monolayer in Dry Age-Related
Amir H Kashani, MD PhD
Updates from the Field
2018

Category: AMD-Non-Neovascular

See more